---
title: "ELSN.US (ELSN.US) — 相关新闻"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/ELSN.US/news.md"
symbol: "ELSN.US"
name: "ELSN.US"
parent: "https://longbridge.com/zh-CN/quote/ELSN.US.md"
datetime: "2026-03-14T05:31:03.885Z"
locales:
  - [en](https://longbridge.com/en/quote/ELSN.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/ELSN.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/ELSN.US/news.md)
---

> 支持的语言: [English](https://longbridge.com/en/quote/ELSN.US/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/ELSN.US/news.md)


# ELSN.US (ELSN.US) — 相关新闻

### [Elite Pharmaceuticals Q3 Earnings Call Highlights](https://longbridge.com/zh-CN/news/276301735.md)
*2026-02-19T05:07:43.000Z*
> Elite Pharmaceuticals reported a significant increase in revenue and profit for Q3 of fiscal 2026, with total revenue re

### [Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Third Quarter 2026 Financial Results on February 18, 2026 | ELTP Stock News](https://longbridge.com/zh-CN/news/275661447.md)
*2026-02-11T13:30:00.000Z*
> Elite Pharmaceuticals, Inc. will release its third quarter financial results for fiscal year 2026 on February 17, 2026. 

### [US IPO Week Ahead: At least 8 sizable IPOs teed up in one of the busiest weeks in four years](https://longbridge.com/zh-CN/news/274527255.md)
*2026-02-02T14:30:38.000Z*
> Eight IPOs raising at least $100 million are scheduled for the upcoming week, marking the busiest week for sizable offer

### [US IPO Week Ahead: At least 7 sizable IPOs teed up in one of the busiest weeks in four years](https://longbridge.com/zh-CN/news/274368356.md)
*2026-01-31T00:27:57.000Z*
> Seven IPOs raising at least $100 million are scheduled for the upcoming week, marking one of the busiest weeks for sizab

### [Merck Expected to Take $30 Million Stake in Eikon Therapeutics' IPO](https://longbridge.com/zh-CN/news/274189036.md)
*2026-01-29T18:08:35.000Z*
> Merck Expected to Take $30 Million Stake in Eikon Therapeutics' IPO

### [Cancer-Busting Biopharma Group Eikon Therapeutics Set to be Valued at Near $1B in IPO](https://longbridge.com/zh-CN/news/274020237.md)
*2026-01-28T16:40:50.000Z*
> Eikon Therapeutics, a biopharmaceutical company focused on cancer treatment, aims for a valuation of nearly $1 billion i

### [07:33 ET
			
			
				Elysium Therapeutics Raises $7.5 Million SAFE Round to Accelerate Development of Novel Rescue Therapy Designed to Specifically Combat Oral Fentanyl Overdose](https://longbridge.com/zh-CN/news/273990243.md)
*2026-01-28T12:33:46.000Z*
> Elysium Therapeutics has raised $7.5 million in a SAFE round to advance its SOOPR™ technology, aimed at preventing and r

### [BRIEF-Eikon Therapeutics Inc - IPO Price Per Share Estimated Between $16.00 And $18.00 - SEC Filing](https://longbridge.com/zh-CN/news/273985563.md)
*2026-01-28T11:44:00.000Z*
> Jan 28 (Reuters) - * ‌EIKON ​THERAPEUTICS INC - ‍IPO ⁠PRICE ⁠PER ‌SHARE ​ESTIMATED BETWEEN $16.00 ⁠AND $18.00 - ‍SEC ​FI